SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Annual financial filings compiled by Axios Friday show that 10 of the nation's top healthcare CEOs took home more than $300 million in combined pay in 2019, compensation that Sen. Bernie Sanders denounced as "outrageous" and indicative of the industry's greed.
"While Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 healthcare CEOs made over $300 million in compensation last year," tweeted Sanders, a 2020 Democratic presidential candidate.
"We will end the greed of the pharmaceutical industry and pass Medicare for All," added Sanders, who has been targeted by industry-backed ad campaigns against universal healthcare.
\u201cWhile Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 health cares CEOs made over $300 million in compensation last year.\n\nOutrageous.\n\nWe will end the greed of the pharmaceutical industry and pass Medicare for All.\u201d— Bernie Sanders (@Bernie Sanders) 1583516703
Axios reported that the executives' eye-popping compensation in 2019 "mostly came from large stock gains."
Ari Bousbib, CEO of pharmaceutical data firm IQVIA, raked in more than $104 million in 2019, according to Axios' healthcare executive compensation tracker. Gary Guthart, CEO of clinical technology firm Intuitive Surgical CEO, brought home nearly $50.5 million. David Ricks, chief executive at pharmaceutical giant Eli Lilly, made over $30 million.
"The healthcare system is a firehose of spending," Axios noted, "and a good chunk of that money always makes its way to the top."
Political revenge. Mass deportations. Project 2025. Unfathomable corruption. Attacks on Social Security, Medicare, and Medicaid. Pardons for insurrectionists. An all-out assault on democracy. Republicans in Congress are scrambling to give Trump broad new powers to strip the tax-exempt status of any nonprofit he doesn’t like by declaring it a “terrorist-supporting organization.” Trump has already begun filing lawsuits against news outlets that criticize him. At Common Dreams, we won’t back down, but we must get ready for whatever Trump and his thugs throw at us. Our Year-End campaign is our most important fundraiser of the year. As a people-powered nonprofit news outlet, we cover issues the corporate media never will, but we can only continue with our readers’ support. By donating today, please help us fight the dangers of a second Trump presidency. |
Annual financial filings compiled by Axios Friday show that 10 of the nation's top healthcare CEOs took home more than $300 million in combined pay in 2019, compensation that Sen. Bernie Sanders denounced as "outrageous" and indicative of the industry's greed.
"While Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 healthcare CEOs made over $300 million in compensation last year," tweeted Sanders, a 2020 Democratic presidential candidate.
"We will end the greed of the pharmaceutical industry and pass Medicare for All," added Sanders, who has been targeted by industry-backed ad campaigns against universal healthcare.
\u201cWhile Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 health cares CEOs made over $300 million in compensation last year.\n\nOutrageous.\n\nWe will end the greed of the pharmaceutical industry and pass Medicare for All.\u201d— Bernie Sanders (@Bernie Sanders) 1583516703
Axios reported that the executives' eye-popping compensation in 2019 "mostly came from large stock gains."
Ari Bousbib, CEO of pharmaceutical data firm IQVIA, raked in more than $104 million in 2019, according to Axios' healthcare executive compensation tracker. Gary Guthart, CEO of clinical technology firm Intuitive Surgical CEO, brought home nearly $50.5 million. David Ricks, chief executive at pharmaceutical giant Eli Lilly, made over $30 million.
"The healthcare system is a firehose of spending," Axios noted, "and a good chunk of that money always makes its way to the top."
Annual financial filings compiled by Axios Friday show that 10 of the nation's top healthcare CEOs took home more than $300 million in combined pay in 2019, compensation that Sen. Bernie Sanders denounced as "outrageous" and indicative of the industry's greed.
"While Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 healthcare CEOs made over $300 million in compensation last year," tweeted Sanders, a 2020 Democratic presidential candidate.
"We will end the greed of the pharmaceutical industry and pass Medicare for All," added Sanders, who has been targeted by industry-backed ad campaigns against universal healthcare.
\u201cWhile Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 health cares CEOs made over $300 million in compensation last year.\n\nOutrageous.\n\nWe will end the greed of the pharmaceutical industry and pass Medicare for All.\u201d— Bernie Sanders (@Bernie Sanders) 1583516703
Axios reported that the executives' eye-popping compensation in 2019 "mostly came from large stock gains."
Ari Bousbib, CEO of pharmaceutical data firm IQVIA, raked in more than $104 million in 2019, according to Axios' healthcare executive compensation tracker. Gary Guthart, CEO of clinical technology firm Intuitive Surgical CEO, brought home nearly $50.5 million. David Ricks, chief executive at pharmaceutical giant Eli Lilly, made over $30 million.
"The healthcare system is a firehose of spending," Axios noted, "and a good chunk of that money always makes its way to the top."